Adjunctive therapy in Parkinson's disease: the role of rasagiline
Kathryn D Gaines,1 Vanessa K Hinson21Department of Neurology, Aurora Advanced Healthcare, Milwaukee, WI, 2Department of Neurosciences, Movement Disorders Program, Medical University of South Carolina, Charleston, SC, USAAbstract: Parkinson's disease is the second most common neurodegener...
Enregistré dans:
Auteurs principaux: | Gaines KD, Hinson VK |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aa42f0d91b954ce2a8df80a3d2961a92 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Rasagiline in treatment of Parkinson’s disease
par: Lakshmi Nayak, et autres
Publié: (2008) -
Review: management of Parkinson's disease
par: Pedrosa DJ, et autres
Publié: (2013) -
Do neurologists in Germany adhere to the national Parkinson's disease guideline?
par: Sabrina Schröder, et autres
Publié: (2011) -
Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
par: Leahy JT, et autres
Publié: (2011) -
Editor's choice
par: Pinder RM
Publié: (2012)